BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8549419)

  • 1. Activity of quinolones against mycobacteria.
    Jacobs MR
    Drugs; 1995; 49 Suppl 2():67-75. PubMed ID: 8549419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of quinolones against mycobacteria.
    Jacobs MR
    Drugs; 1999; 58 Suppl 2():19-22. PubMed ID: 10553700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M; Gutierrez J; Ruiz P; Moreno G
    Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
    Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
    J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
    Dailloux M; Petitpain N; Henry C; Weber M
    Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.
    Guillemin I; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2084-8. PubMed ID: 9687411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimycobacterial activities of a new quinolone, sparfloxacin].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.
    Klopman G; Fercu D; Renau TE; Jacobs MR
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2637-43. PubMed ID: 8913479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in-vitro activity of sparfloxacin and eight other antimicrobial agents against clinical isolates of non-tuberculous mycobacteria.
    Sánchez-Carrillo C; Cotarelo M; Cercenado E; Vicente T; Blázquez R; Bouza E
    J Antimicrob Chemother; 1996 Jan; 37(1):151-4. PubMed ID: 8647757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp.
    Van Caekenberghe D
    J Antimicrob Chemother; 1990 Sep; 26(3):381-6. PubMed ID: 2228828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position.
    Renau TE; Gage JW; Dever JA; Roland GE; Joannides ET; Shapiro MA; Sanchez JP; Gracheck SJ; Domagala JM; Jacobs MR; Reynolds RC
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2363-8. PubMed ID: 8891145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic potential of sparfloxacin for preventing mycobacterial infections].
    Kawahara S; Tada A; Takeuchi M; Kamisaka K; Okada C; Mishima Y; Soda R; Takahashi K; Kibata M; Nagare H
    Kekkaku; 1994 May; 69(5):351-6. PubMed ID: 8007520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical use of fluoroquinolones for the treatment of mycobacterial diseases.
    Alangaden GJ; Lerner SA
    Clin Infect Dis; 1997 Nov; 25(5):1213-21. PubMed ID: 9402384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in-vitro activity of fleroxacin and other 6-fluoroquinolones against mycobacteria.
    Salfinger M; Hohl P; Kafader FM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():55-63. PubMed ID: 3144550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activities of quinolones against mycobacteria.
    Garcia-Rodriguez JA; Gomez Garcia AC
    J Antimicrob Chemother; 1993 Dec; 32(6):797-808. PubMed ID: 8144420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
    Young LS; Berlin OG; Inderlied CB
    Am J Med; 1987 Apr; 82(4A):23-6. PubMed ID: 3107379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antimycobacterial activity of a new quinolone, NM394].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.